SCHEMBL13076276

SCHEMBL13076276

Cc1nn(C)c(C)c1-c1cc(C(=O)c2nc3ccc(OCCN4CCN(C)CC4)nc3[nH]2)ccc1N

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 2/20 0.38
CCND1 P24385 2/20 0.38
CCND3 P30281 1/20 0.38
CDK6 Q00534 1/20 0.38
MCL1 Q07820 3/20 0.34
ALB P02768 1/20 0.34
FGFR1 P11362 1/20 0.34
FGFR2 P21802 1/20 0.34
FGFR3 P22607 1/20 0.34
PDE5A O76074 3/20 0.34
CDK2 P24941 1/20 0.33
CHUK O15111 3/20 0.33
INSR P06213 3/20 0.33
MAPK8 P45983 3/20 0.33
CAMKK2 Q96RR4 3/20 0.33
NOS3 P29474 1/20 0.33
NOS1 P29475 1/20 0.33
NOS2 P35228 1/20 0.33
PIR O00625 1/20 0.32
BRAF P15056 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL111269 0.90 CDK4 (0.49) CDK4CCND1CCND3CDK6MCL1
SCHEMBL13076282 0.85 CDK4 (0.43) CDK4CCND1CCND3CDK6GSK3B
SCHEMBL110672 0.74 CDK4 (0.55) CDK4CCND1CCND3CDK6CDK2
SCHEMBL13075594 0.73 CDK4 (0.43) CDK4CCND1CCND3CDK6
SCHEMBL2143455 0.69 CDK4 (0.51) CDK4CCND1CCND3CDK6CDK2
SCHEMBL111458 0.69 CDK4 (0.58) CDK4CCND1CCND3CDK6CDK2
SCHEMBL112968 0.69 CDK4 (0.52) CDK4CCND1CCND3CDK6CDK2
SCHEMBL112506 0.68 CDK4 (0.63) CDK4CCND1CCND3CDK6CDK2
SCHEMBL108753 0.68 CDK4 (0.57) CDK4CCND1CCND3CDK6CDK2
SCHEMBL112413 0.68 CDK4 (0.53) CDK4CCND1CCND3CDK6CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010125402-A1 IMIDAZOLE DERIVATIVES AND THEIR USE AS MODULATORS OF CYCLIN DEPENDENT KINASES NOVARTIS AG (CH) 2010-11-04 WO disclosed